Thrombocytosis associated with enoxaparin: A very rare cause in newborns

被引：8

作者：

Tonbul, Alparslan ^{[1
]}

Uras, Nurdan ^{[2
]}

Tayman, Cuneyt ^{[1
]}

Halici, Tugba ^{[1
]}

Polat, Aziz ^{[1
]}

Tatli, Mustafa Mansur ^{[1
]}

机构：

[1] Fatih Univ, Sch Med, Dept Pediat, Div Neonatol, TR-06540 Ankara, Turkey

[2] Dr Zekai Tahir Burak Womens Hlth Educ & Res Hosp, Div Neonatol, Ankara, Turkey

来源：

PLATELETS | 2010年 / 21卷 / 04期

关键词：

Thrombocytosis; enoxaparin; newborn; thrombosis; dalteparin; THROMBOSIS;

D O I：

10.3109/09537101003649807

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Newborn infants are most vulnerable to the development of thrombosis because of the developing neonatal hemostatic system, perinatal risk factors and different types of medical conditions. Enoxaparin is the current anticoagulant of choice with advantages for the treatment of neonatal thrombosis. Thrombocytosis induced by enoxaparin has been reported as a rare adverse effect of this medication in adults. However, to our knowledge, in newborns there have been no reported cases to date of thrombocytosis induced by enoxaparin.

引用

页码：300 / 302

页数：3

共 13 条

[1] Reactive thrombocytosis associated with enoxaparin [J].

Hummel, Margaret C. ;

Morse, Bryan C. ;

Hayes, Lloyd E. .

PHARMACOTHERAPY, 2006, 26 (11) :1667-1670

[2] Neonatal renal vein thrombosis: Review of the english-language literature between 1992 and 2006 [J].

Lau, Keith K. ;

Stoffman, Jayson M. ;

Williams, Suzane ;

McCusker, Patricia ;

Brandao, Leonardo ;

Patel, Sanjay ;

Chan, Anthony K. C. .

PEDIATRICS, 2007, 120 (05) :E1278-E1284

[3]

Liautard C, 2002, ANN PHARMACOTHER, V36, P1351

[4] Enoxaparin for neonatal thrombosis: A call for a higher dose for neonates [J].

Malowany, Janet I. ;

Monagle, Paul ;

Knoppert, David C. ;

Lee, David S. C. ;

Wu, John ;

McCusker, Patricia ;

Massicotte, M. Patricia ;

Williams, Suzan ;

Chan, Anthony K. C. .

THROMBOSIS RESEARCH, 2008, 122 (06) :826-830

[5] Enoxaparin use in the neonatal intensive care unit: Experience over 8 years [J].

Malowany, Janet I. ;

Knoppert, David C. ;

Chan, Anthony K. C. ;

Pepelassis, Dion ;

Lee, David S. C. .

PHARMACOTHERAPY, 2007, 27 (09) :1263-1271

[6]

Mantadakis E, 2008, INDIAN PEDIATR, V45, P669

[7] Renal outcome of neonatal renal venous thrombosis: Review of 28 patients and effectiveness of fibrinolytics and heparin in 10 patients [J].

Messinger, Yoav ;

Sheaffer, Jan Watterson ;

Mrozek, Jeanne ;

Smith, Clark M. ;

Sinaiko, Alan R. .

PEDIATRICS, 2006, 118 (05) :E1478-E1484

[8] The low molecular weight heparin dalteparin for prophylaxis and therapy of thrombosis in childhood:: a report on 48 cases [J].

Nohe, N ;

Flemmer, A ;

Rümler, R ;

Praun, M ;

Auberger, K .

EUROPEAN JOURNAL OF PEDIATRICS, 1999, 158 (Suppl 3) :S134-S139

[9] Thrombocytosis associated with low-molecular-weight heparin [J].

Rizzieri, DA ;

Wong, WM ;

Gockerman, JP .

ANNALS OF INTERNAL MEDICINE, 1996, 125 (02) :157-157

[10] Neonatal thromboembolic emergencies [J].

Thornburg, Courtney ;

Pipe, Steven .

SEMINARS IN FETAL & NEONATAL MEDICINE, 2006, 11 (03) :198-206

← 1 2 →